Subject: Re: Div stocks
I noticed Pfizer's attractive dividend and apparently reasonable share price, and briefly considered buying some last week.
After a quick review of materials available online, I decided, rightly or wrongly, to pass. Chief among my reasons was Pfizer's mid-December $43 billion purchase of Seagen. I am always somewhat skittish about large mergers and, with this one just beginning to be implemented, my uncertainty increased. See also "Pfizer Buys Seagen - Why This Deal May Not Please Shareholders" by Edmund Ingham, SeekingAlpha.com (03/13/2023).
Pfizer currently may be the best buy since sliced bread; just not for me.

Good luck!

Philmordun